Native Mass\nSpectrometry Reveals Binding Interactions\nof SARS-CoV‑2 PLpro with Inhibitors and Cellular Targets

Here\nwe used native mass spectrometry (native MS) to probe a SARS-CoV\nprotease, PLpro, which plays critical roles in coronavirus disease\nby affecting viral protein production and antagonizing host antiviral\nresponses. Ultraviolet photodissociation (UVPD) and variable temperature\nelectrospray ionization (vT ESI) were used to localize binding sites\nof PLpro inhibitors and revealed the stabilizing effects of inhibitors\non protein tertiary structure. We compared PLpro from SARS-CoV-1 and\nSARS-CoV-2 in terms of inhibitor and ISG15 interactions to discern\npossible differences in protease function. A PLpro mutant lacking\na single cysteine was used to localize inhibitor binding, and thermodynamic\nmeasurements revealed that inhibitor PR-619 stabilized the folded\nPLpro structure. These results will inform further development of\nPLpro as a therapeutic target against SARS-CoV-2 and other emerging\ncoronaviruses.

Publication Details

Journal
Figshare
Published
2024-09-20
DOI
https://doi.org/10.1021/acsinfecdis.4c00444.s001
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Native Mass\nSpectrometry Reveals Binding Interactions\nof SARS-CoV‑2 PLpro with Inhibitors and Cellular Targets

Figshare
Computational Drug Discovery Methods
article

Native Mass\nSpectrometry Reveals Binding Interactions\nof SARS-CoV‑2 PLpro with Inhibitors and Cellular Targets

article en

Abstract

Here\nwe used native mass spectrometry (native MS) to probe a SARS-CoV\nprotease, PLpro, which plays critical roles in coronavirus disease\nby affecting viral protein production and antagonizing host antiviral\nresponses. Ultraviolet photodissociation (UVPD) and variable temperature\nelectrospray ionization (vT ESI) were used to localize binding sites\nof PLpro inhibitors and revealed the stabilizing effects of inhibitors\non protein tertiary structure. We compared PLpro from SARS-CoV-1 and\nSARS-CoV-2 in terms of inhibitor and ISG15 interactions to discern\npossible differences in protease function. A PLpro mutant lacking\na single cysteine was used to localize inhibitor binding, and thermodynamic\nmeasurements revealed that inhibitor PR-619 stabilized the folded\nPLpro structure. These results will inform further development of\nPLpro as a therapeutic target against SARS-CoV-2 and other emerging\ncoronaviruses.

Figshare
Openalex Percentile: Top 63%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.